Nu-Med Plus (NUMD) 10-Q 17 May 21 2021 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2021	May 17, 2021
Details
Registrant CIK	0001543637
Fiscal Year End	--12-31
Registrant Name	Nu-Med Plus, Inc.
SEC Form	10-Q
Period End date	Mar. 31, 2021
Tax Identification Number (TIN)	45-3672530
Number of common stock shares outstanding		79,348,469
Filer Category	Non-accelerated Filer
Current with reporting	Yes
Interactive Data Current	Yes
Shell Company	false
Small Business	true
Emerging Growth Company	true
Ex Transition Period	false
Entity File Number	000-54808
Entity Incorporation, State or Country Code	UT
Entity Address, Address Line One	455 East 500 South, Suite 203
Entity Address, City or Town	Salt Lake City
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84111
City Area Code	801
Local Phone Number	746-3570
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Document Quarterly Report	true
Document Transition Report	false

Balance Sheets

Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current assets
Cash	$ 139,265	$ 188,506
Prepaid expense	131,778	349,017
Total current assets	271,043	537,523
Long-term assets
Property and equipment, net	8,982	11,631
Operating lease right-of-use of assets	4,988	7,981
Total long-term assets	13,970	19,612
Total assets	285,013	557,135
Current liabilities
Accounts payable	12,645	26,048
Accounts payable - related party	26,000	20,000
Accrued Expense	41,041	26,019
Operating lease liability	4,988	7,981
Total current liabilities	84,674	80,048
Long-term liabilities
Note payable	9,384	9,384
Total liabilities	94,058	89,432
Commitments and contingencies	0	0
Stockholders' equity
Preferred stock; $0.001 par value; 10,000,000 authorized; no shares issued and outstanding, respectively.	0	0
Common stock; $0.001 par value; 90,000,000 authorized; 79,348,469 and 51,028,469 shares issued and outstanding, as of March 31, 2021 and December 31, 2020, respectively.	79,349	51,029
Additional paid-in capital	9,207,587	8,431,593
Stock subscription payable	0	724,314
Accumulated deficit	(9,095,981)	(8,739,233)
Total stockholders' equity	190,955	467,703
Total liabilities and stockholders' equity	$ 285,013	$ 557,135

Balance Sheets - Parenthetical

Balance Sheets - Parenthetical - $ / shares	Mar. 31, 2021	Dec. 31, 2020
Details
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	90,000,000	90,000,000
Common Stock, Shares, Issued	79,348,469	51,028,469
Common Stock, Shares, Outstanding	79,348,469	51,028,469

Statements of Operations

Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Details
Revenue	$ 0	$ 0
Operating expenses
General and administrative expense	7,834	8,404
Payroll expense	69,248	64,475
Rent expense	6,264	4,689
Professional and consulting fees	270,515	65,697
Depreciation expense	2,649	3,048
Total operating expenses	356,748	149,313
Operating Loss	(356,748)	(149,313)
Other income/expense
Interest expense	0	(4,021)
Total other income/expense	0	(4,021)
Net income (loss) before income taxes	(356,748)	(153,334)
Income tax expense	0	0
Net income (loss)	$ (356,748)	$ (153,334)
Basic and diluted income (loss) per share	$ 0	$ 0
Weighted average common shares outstanding - basic and diluted	79,276,469	46,553,585

Statement of Stockholders' Defi

Statement of Stockholders' Deficit - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Other Additional Capital	Retained Earnings	Total
Preferred Stock, Shares Outstanding, Beginning Balance at Dec. 31, 2019	0
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2019		44,476,625
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2019	$ 0	$ 44,477	$ 5,849,784	$ 465,541	$ (6,730,234)	$ (370,432)
Stock issued for cash						0
Stock issued for services performed	0	0	50,000	0	0	50,000
Net income (loss)	0	$ 0	0	0	(153,334)	(153,334)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2020		44,476,625
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2020		$ 44,447	5,899,784	571,980	(6,883,568)	(367,327)
Stock subscription payable - cash	$ 0	$ 0	0	106,439	0	$ 106,439
Preferred Stock, Shares Outstanding, Beginning Balance at Dec. 31, 2020	0					0
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2020		51,028,469				51,028,469
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2020	$ 0	$ 51,029	8,431,593	724,314	(8,739,233)	$ 467,703
Stock issued for cash		120,000				120,000
Stock issued for cash	0	$ 120	29,880	0	0	$ 30,000
Stock issued for services performed	0	$ 0	50,000	0	0	50,000
Common Stock issued under subscription		28,200,000
Proceeds from issuance of common stock	0	$ 28,200	696,114	(724,314)	0	0
Net income (loss)	$ 0	$ 0	0	0	(356,748)	$ (356,748)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2021		79,348,469				79,348,469
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2021		$ 79,349	$ 9,207,587	$ 0	$ (9,095,981)	$ 190,955
Stock subscription payable - cash						$ 0

Statements of Cash Flows

Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities:
Net income (loss)	$ (356,748)	$ (153,334)
Adjustment to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	2,649	3,048
Amortization of right of use asset	2,993	3,024
Stock issued for services performed	50,000	50,000
(Increase) decrease in prepaid expenses	217,239	3,737
(Increase) decrease in operating lease liability	(2,993)	(3,024)
(Decrease) increase in accounts payable	(13,403)	(4,312)
Decrease in related party payables	6,000	0
Increase (decrease) in accrued expense	15,022	5,671
Net cash used in operating activities	(79,241)	(95,190)
Cash flows from investing activities:
Net cash used in investing activities	0	0
Cash flows from financing activities
Stock subscription payable - cash	0	106,439
Proceeds from note payable	0	0
Proceeds from issuance of common stock	30,000	0
Net cash provided by financing activities	30,000	106,439
Net increase (decrease) in cash	(49,241)	11,249
Cash at beginning of period	188,506	7,079
Cash at end of period	139,265	18,328
Supplemental schedule of cash flow information
Cash paid for interest	0	0
Cash paid for income tax	0	0
Supplemental schedule of non-cash financing activities
Common stock issued for subscription payable	$ 724,314	$ 0

Organization and Description of

Organization and Description of Business	3 Months Ended
	Mar. 31, 2021
Notes
Organization and Description of Business	The recent COVID 19 Pandemic (“the Pandemic”) has had a dramatic effect on our business as well as the business of our contract developers. The wide ranging effects on the World Wide business market has led to a closure or partial closure of firms we are relying on in our product development. As a result their work on our project has been slowed. While we cannot predict when the influence of the Pandemic will end, we trust businesses will be able to open and expand activities to their former levels and increase following a return to normal operations. NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES a. Basis of Presentation The accompanying unaudited condensed consolidated financial statements include the accounts of Nu-Med Plus, Inc. (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Nu-Med Plus, Inc. for the year ended December 31, 2019 included in the Company’s Form 10-K filed with the Securities and Exchange Commission on March 30, 2020. In particular, the Company’s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2020. b. Revenue Recognition The Financial Accounting Standards Board (“FASB”) issued new guidance for the recognizing and reporting of revenue, ASU 2014-09, Revenue from Contracts with Customers (“ASC606”). The effective date for implementation for public companies was January 1, 2018. The new guidance established a five-step analysis to be followed when determining the recognition of revenue. 1. 2. 3. 4. 5. While the Company is an early-stage company with no revenue, at the time we begin to generate revenue the Company will recognize such revenue in conformity with the guidelines set forth by ASC 606. c. Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. d. Cash and Cash Equivalents The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents. The cash balance we currently have on deposit is within the limits for which the FDIC insures. e. Property and Equipment Property and equipment is stated at cost. Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures, exceeding $500, for new assets or that increase the useful life of existing assets are capitalized. Depreciation is computed using the straight-line method. The lives over which the fixed assets are depreciated are five to seven years. f. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB Accounting Standards Codification (“ASC”) Topic 820 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements), as follows: Level 1 - Quoted market prices in active markets for identical assets or liabilities; Level 2 - Inputs other than level one inputs that are either directly or indirectly observable; and Level 3 - Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use. All cash, accounts payable and accrued liabilities are carried at cost, which approximates fair value due to the short-term nature of these financial instruments. Additionally, we measure certain financial instruments at fair value on a recurring basis. g. Earnings per Share The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement. The company included 0 and 2,287,920 shares subscribed but unissued in its calculation of basic and diluted earnings per share for the three months ended March 31, 2021 and 2020, respectively. Three months ended March 31, 2021 Three months ended March 31, 2020 Net (loss) earnings (numerator) $(356,748) $(153,334) Shares (denominator) 79,348,469 46,553,585 Net earnings per share amount – basic and diluted $(0.00) $(0.00) Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period. As of March 31, 2021 and 2020 there were 0 and 34,835,200, respectively, potential dilutive shares, or common share equivalents from convertible notes payable. As of March 31, 2021 and 2020 the dilutive shares were excluded from the calculation for diluted earnings per share as there was a net loss and their inclusion in the calculation would be anti-dilutive. h. Concentrations and Credit Risk The Company has relied on a small group of investors to fund its operations. If this group becomes unable or unwilling to provide additional funding, the Company may be unable to remain in business or to execute on its business plan. i. Income Taxes Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. j. Stock-based Compensation The Company, in accordance with ASC 718, Compensation – Stock Compensation Measurement Objective – Fair Value at Grant Date k. Leases The Company accounts for all leases in accordance with ASC 842, Leases l. Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

GOING CONCERN

GOING CONCERN	3 Months Ended
	Mar. 31, 2021
Notes
GOING CONCERN	NOTE 2 - GOING CONCERN The Company acknowledges that the funds on hand as of March 31, 2021, will not be sufficient to enable it to execute its business plan and will require funding through the sale of equity capital and short term related party and other shareholder loans in order to meet the planned expenditures for development, operations, and administrative cost over the next 12 months will be required. Planned expenditures are approximately $1,200,000 for the next twelve months. The Company is currently funded through July 31, 2021. If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk. These factors raise substantial doubt about the Company's ability to continue as a going concern.

Property and Equipment

Property and Equipment	3 Months Ended
	Mar. 31, 2021
Notes
Property and Equipment	NOTE 3 – PROPERTY AND EQUIPMENT Property and equipment and related accumulated depreciation consisted of the following at March 31, 2021, and December 31, 2020: March 31, 2021 December 31, 2020 Computer and office equipment $ 90,368 $ 90,368 Accumulated depreciation (81,386) (78,737) Total Fixed Assets $ 8,982 $ 11,631 Depreciation expense for the three months ended March 31, 2021 and 2020 was $2,649 and $3,048, respectively.

Preferred and Common Stock

Preferred and Common Stock	3 Months Ended
	Mar. 31, 2021
Notes
Preferred and Common Stock	NOTE 4 - PREFERRED STOCK On October 19, 2011, the Company filed Articles of Incorporation with the State of Utah so as to authorize 10,000,000 shares of preferred stock having a par value of $0.001 per share. No preferred shares are issued or outstanding at March 31, 2021. NOTE 5 - COMMON STOCK Stock Subscription Payable At March 31, 2021 and December 31, 2020, the Company had $0 and $724,314, respectively, in stock subscriptions payable for which it is obligated to issue 0 and 28,902,684 shares of restricted common stock, respectively, pursuant to separate subscription agreements. April 2020 Subscription Agreement In April 2020, the Company entered into a stock purchase agreement with a related party, significant shareholder and debt holder, under which the buyer may purchase up to $400,000 in shares of common stock at $0.25 per share. The agreement expires on December 31, 2021. On October 6, 2020 the Company received notice that the related party wished to convert the remaining balance of stock purchased under the agreement, which balance was $175,672, into shares of restricted common stock. The stock was issued during the three months ended March 31, 2021 and as of that date the Company has no stock subscription payable. Common Stock Issued for Cash During the three months ending March 31, 2021, the Company issued 120,000 shares of restricted common stock for $30,000 to an unrelated investor. Common Stock Issued for conversion of liabilities During the three months ended March 31, 2021, the Company issued 28,200,000 shares of restricted common stock in full settlement of its obligations under convertible notes, accrued interest, and stock subscriptions payable, in full settlement of its obligations under those agreements. Common Stock Issued for Services During 2020 the Company issued 1,545,000 shares of restricted common stock to consultants for services performed and/or to be performed. The issuances were valued at $1,066,650 and are to be amortized over the life of the respective agreements. For the three months ended March 31, 2021 the Company recorded an expense of $215,465 related to these agreements. There was no expense recognized for these agreements in the three months ended March 31, 2020. As of March 31, 2021, the prepaid balance of $128,593 remains to be amortized as the services are performed.

Convertible Notes and Derivativ

Convertible Notes and Derivative Liability	3 Months Ended
	Mar. 31, 2021
Notes
Convertible Notes and Derivative Liability	NOTE 6 – CONVERTIBLE POMISSORY NOTES – Related Party $100,000 Convertible Promissory Note On November 12, 2012, the Company issued a $100,000 convertible promissory note to SCS, a related party and significant shareholder, as compensation for services provided during the period April 1, 2012 through March 31, 2013. The note is due on demand, had an annual interest of 5.5%, and is convertible into shares of common stock at a conversion price to be agreed upon immediately prior to conversion. On September 27, 2013, the Company amended the note to include a conversion price which of $0.01 per share for all unpaid principal and interest. On October 22, 2020 the Company was notified by the note holder that it intended to convert the note and accrued interest into shares of the Company’s restricted common stock. $130,100 Convertible Promissory Note Prior to 2015, the Company entered into a convertible promissory note with SCS, a related party and significant shareholder, due on demand, bearing interest at 8% per annum, unsecured and convertible at $0.01 per share, with a price protection provision to a lower conversion price. During the nine-month period ended September 30, 2020, the Company received a request to convert $10,000of interest accrued and unpaid to shares of restricted common stock. Under the conversion terms of the agreement 1,000,000shares of restricted stock were issued. On October 22, 2020 the Company was notified by the note holder that it intended to convert the note and accrued interest into shares of the Company’s restricted common stock. Subsequent to receiving the intent of the note holder to convert the notes and accrued interest into restricted common stock the principal of the notes and all accrued interest was reclassified and shown as a stock subscription payable at December 31, 2020. On March 23, 2021 the principal and accrued interest were converted to 28,000,000 shares of restricted common stock. No gain on extinguishment of debt was recorded on this transaction as it was with a related party. NOTE 7 - NOTES – OTHER $9,384 Promissory Note The Company applied for and received a $9,384 loan under the Paycheck Protection Program administered by the Small Business Administration. The note bears an annual interest rate of 1% and has a maturity date of May 8, 2022. The terms of the loan provide that an application for forgiveness of the loan amount may be requested if the funds were used for payroll, medical insurance, rent and utilities. As all of the funds were used in the allowable categories, the Company will file an application for forgiveness as soon as the bank makes available the form for such request.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2021
Notes
Commitments and Contingencies	NOTE 8 - COMMITMENTS AND CONTINGENCIES The Company has obligations under both a financing lease and operating lease, as detailed below. Operating Lease Obligations The Company entered into a lease for office space in February 2017 and has signed various extensions since then, the latest of which expired on August 31, 2020. In August 2020 the Company extended the lease agreement through August 31, 2021 at a rate of $1,038 per month. Amortization of $2,993 was recorded as rent expense in the three month period ending March 31, 2021, leaving an operating right-of-use asset at March 31, 2021 of $4,988 and an operating lease liability of $4,988. Cash payments of $6,264 were made for rent expense in the three months ended March 31, 2021. Obligations under this lease are as follows: 2021 2022 2023 Office lease $ 5,190 $ - $ - Upon the adoption of ASC 842, the calculation of our lease obligation using a discount rate of 8% resulted in an immaterial difference and therefore, no interest will be imputed on the lease obligation. There are five months remaining on the office lease, which terminates August 31, 2021. Consulting Agreement In September 2020, the Company entered into a consulting agreement with Waterside Capital Advisers, Inc. to raise capital for the Company and provide other consulting services. Under the terms of the agreement, 50,000 shares of common stock were to be issued upon signing the agreement, 75,000 shares of common stock were to be issued 30 days after the signing date and an additional 75,000 shares are to be issued 60 days after the signing date. Accordingly, the Company valued the shares at $200,000 of which was expended in the year ended December 31, 2020. In addition, the agreement provides that the consultant be paid $5,000 per month for services, which fee will be accrued until such time as the Company and consultant agree acceptable financing has been raised, at which point payment of all accrued but unpaid fees will be made. In accordance with the agreement a $15,000 consultant fee was accrued for the three months ended March 31, 2021. Further, the agreement contains a long-term incentive whereby an additional 2,000,000 shares of common stock may be earned by the consultant upon the achieving of certain milestones as detailed in the agreement. In June 2020, the Company entered into consulting agreements with Roger Gill and Peter Kristensen. Both of the agreements begin June 22, 2020 and run for a period of twelve months, terminating June 30, 2021. Under the terms of the agreements Mr. Gill will receive 500,000 shares of restricted common stock and Mr. Kristensen will receive 100,000 shares of restricted stock for their services. The fair-value of the stock was $565,500 and was recorded as a prepaid. During the three months ended March 31, 2021, the company amortized $139,438 of the prepaid expense. As of March 31, 2021, there is a remaining balance of $128,593 to be amortized over the term of the agreements. On March 15, 2020 the Company entered into a service agreement with an investor relations/public relations firm to provide advisory services to the Company. The contract is a one year contract, but may be cancelled with thirty days notice any time after the 91 st day of the agreement. Under the agreement the consultant receives a fee of $ 3,500 per month, from which fee it pays all of its expenses. In addition, consultant received 750,000 shares of restricted common stock, earned in quarterly tranches of 187,500 shares, deemed earned and issuable after services are provided for each quarter. As of March 31, 2021 all of the shares to which the Company is obligated under this agreement have been issued and earned. The shares were issued at $ 0.50 per share for a total value of $ 375,000 . The amount has been recorded in prepaid expenses, with the final $ 76,027 being expensed in the three-month period ended March 31, 2021.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2021
Notes
Subsequent Events	NOTE 9 - SUBSEQUENT EVENTS On May 13, 2021, the Company received notice that its application for forgiveness of the PPP loan had been approved, with all principal and accrued interest forgiven. The Company has evaluated subsequent events pursuant to ASC Topic 855 and has determined that there are no other events that require disclosure as of the date of issuance.

Organization and Description _2

Organization and Description of Business (Policies)	3 Months Ended
	Mar. 31, 2021
Policies
Accounting Method	a. Basis of Presentation The accompanying unaudited condensed consolidated financial statements include the accounts of Nu-Med Plus, Inc. (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Nu-Med Plus, Inc. for the year ended December 31, 2019 included in the Company’s Form 10-K filed with the Securities and Exchange Commission on March 30, 2020. In particular, the Company’s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2020.
Revenue Recognition	b. Revenue Recognition The Financial Accounting Standards Board (“FASB”) issued new guidance for the recognizing and reporting of revenue, ASU 2014-09, Revenue from Contracts with Customers (“ASC606”). The effective date for implementation for public companies was January 1, 2018. The new guidance established a five-step analysis to be followed when determining the recognition of revenue. 1. 2. 3. 4. 5. While the Company is an early-stage company with no revenue, at the time we begin to generate revenue the Company will recognize such revenue in conformity with the guidelines set forth by ASC 606.
Estimates	c. Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	d. Cash and Cash Equivalents The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents. The cash balance we currently have on deposit is within the limits for which the FDIC insures.
Property and equipment	e. Property and Equipment Property and equipment is stated at cost. Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures, exceeding $500, for new assets or that increase the useful life of existing assets are capitalized. Depreciation is computed using the straight-line method. The lives over which the fixed assets are depreciated are five to seven years.
Fair Value	f. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB Accounting Standards Codification (“ASC”) Topic 820 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements), as follows: Level 1 - Quoted market prices in active markets for identical assets or liabilities; Level 2 - Inputs other than level one inputs that are either directly or indirectly observable; and Level 3 - Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use. All cash, accounts payable and accrued liabilities are carried at cost, which approximates fair value due to the short-term nature of these financial instruments. Additionally, we measure certain financial instruments at fair value on a recurring basis.
Earnings Per Share	g. Earnings per Share The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement. The company included 0 and 2,287,920 shares subscribed but unissued in its calculation of basic and diluted earnings per share for the three months ended March 31, 2021 and 2020, respectively. Three months ended March 31, 2021 Three months ended March 31, 2020 Net (loss) earnings (numerator) $(356,748) $(153,334) Shares (denominator) 79,348,469 46,553,585 Net earnings per share amount – basic and diluted $(0.00) $(0.00) Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period. As of March 31, 2021 and 2020 there were 0 and 34,835,200, respectively, potential dilutive shares, or common share equivalents from convertible notes payable. As of March 31, 2021 and 2020 the dilutive shares were excluded from the calculation for diluted earnings per share as there was a net loss and their inclusion in the calculation would be anti-dilutive.
Concentration and Credit Risk	h. Concentrations and Credit Risk The Company has relied on a small group of investors to fund its operations. If this group becomes unable or unwilling to provide additional funding, the Company may be unable to remain in business or to execute on its business plan.
Income Taxes	i. Income Taxes Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Equity Instruments Issued For Non-cash Items	j. Stock-based Compensation The Company, in accordance with ASC 718, Compensation – Stock Compensation Measurement Objective – Fair Value at Grant Date
Leases	k. Leases The Company accounts for all leases in accordance with ASC 842, Leases
New Accounting Pronouncements	l. Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

Organization and Description _3

Organization and Description of Business (Tables)	3 Months Ended
	Mar. 31, 2021
Tables/Schedules
Schedule of Earnings Per Share, Basic and Diluted	Three months ended March 31, 2021 Three months ended March 31, 2020 Net (loss) earnings (numerator) $(356,748) $(153,334) Shares (denominator) 79,348,469 46,553,585 Net earnings per share amount – basic and diluted $(0.00) $(0.00)

Property and Equipment (Tables)

Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2021
Tables/Schedules
Property, Plant and Equipment	March 31, 2021 December 31, 2020 Computer and office equipment $ 90,368 $ 90,368 Accumulated depreciation (81,386) (78,737) Total Fixed Assets $ 8,982 $ 11,631

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2021
Tables/Schedules
Schedule of Future Minimum Lease Payments for Capital Leases	2021 2022 2023 Office lease $ 5,190 $ - $ -

Organization and Description _4

Organization and Description of Business (Details) - USD ($)	Dec. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Details
Stock Issued During Period, Shares, Period Increase (Decrease)	28,902,684	0	2,287,920
Net Income (Loss) Available to Common Stockholders, Basic		$ (356,748)	$ (153,334)
Weighted Average Number of Shares Outstanding, Basic		79,348,469	46,553,585
Basic and diluted income (loss) per share		$ 0	$ 0
Dilutive Shares		0	34,835,200

GOING CONCERN (Details)

GOING CONCERN (Details)	3 Months Ended
	Mar. 31, 2021USD ($)
Details
Planned expenditures	$ 1,200,000

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Details
Property, Plant and Equipment, Gross	$ 90,368		$ 90,368
Accumulated Depreciation	(81,386)		(78,737)
Property and equipment, net	8,982		$ 11,631
Depreciation expense	$ 2,649	$ 3,048

Preferred and Common Stock (Det

Preferred and Common Stock (Details) - USD ($)	Dec. 31, 2020	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Apr. 02, 2020
Details
Preferred Stock, Shares Authorized	10,000,000	10,000,000		10,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001		$ 0.001
Common Stock, Share Subscribed but Unissued, Subscriptions Receivable	$ 724,314	$ 0		$ 724,314
Stock Issued During Period, Shares, Period Increase (Decrease)	28,902,684	0	2,287,920
400,000 Stock Subscription Amount		$ 400,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price					$ 0.25
SCS Subscription payable		$ 175,672
Stock issued for cash		120,000
Stock issued for cash		$ 30,000	$ 0
Stock to be issued for conversion of interest on convertible note		28,200,000	1,000,000
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture				1,545,000
1545000 shares issued for services				$ 1,066,650
Other Prepaid Expense, Current		$ 215,465
1545000 shares issued for services amount balance		$ 128,593

Convertible Notes and Derivat_2

Convertible Notes and Derivative Liability (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Nov. 12, 2012
Details
SCS convertible promissory note principal				$ 100,000
SCS convertible promissory note interest rate	5.50%
SCS convertible promissory note conversion price	$ 0.01
130,100 convertible promissory note interest rate	8.00%
130,100 convertible promissory note conversion price	$ 0.01
Stock Issued During Period, Value, Conversion of Convertible Securities	$ 10,000
Stock to be issued for conversion of interest on convertible note	28,200,000	1,000,000
SCS Total settlement shares	28,000,000
Note payable	$ 9,384		$ 9,384

Commitments and Contingencies_2

Commitments and Contingencies (Details) - USD ($)	1 Months Ended	3 Months Ended		12 Months Ended
	Sep. 30, 2020	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Details
monthly office lease payment		$ 1,038
Amortization of right of use asset		2,993	$ 3,024
Operating lease right-of-use of assets		4,988		$ 7,981
Operating lease liability		4,988		$ 7,981
Rent expense		6,264	$ 4,689
Capital Leases, Future Minimum Payments Due, Next Twelve Months		5,190
WatersideCapitalAdvisersigningshares	50,000
WatersideCapitalAdviser30dayshares	75,000
WatersideCapitalAdviser60dayshares	75,000
WatersideCapitalAdvisersharevalue	$ 200,000
Westridge compensation monthly payment		5,000
Westridge compensation quarterly payment		15,000
WatersideCapitalAdviserincentiveshares	2,000,000
Gill shares received in consulting agreement				500,000
Kristensen shares received in consulting agreement				100,000
Gill and Kristensen Consulting shares value total				$ 565,500
Gill and Kristensen Consulting shares amount amortized		139,438
Gill and Kristensen Consulting shares amount remaining		128,593
Hanover compensation monthly payment		$ 3,500
Hanover total compensation shares		750,000
Hanover tranche compensation shares		187,500
Hanover price per share		$ 0.50
Hanover total value		$ 375,000
Hanover Amount To Be Expensed		$ 76,027